Company Name: VBI Vaccines Inc.
VBI Vaccines Inc. is a biopharmaceutical company. The company is engaged in the development of vaccines. The company is using its eVLP (enveloped virus-like particle) vaccine platform to develop its lead product candidate, a prophylactic Cytomegalovirus (CMV) vaccine.
Ticker Symbol: VBIV (NASDAQ)
Company Website: www.vbivaccines.com
Headquarters: Cambridge, MA